Are you working in COVID R&D? Might you have need for a custom biospecimen collection? The MT Group has conducted dozens of COVID biospecimen collections since the beginning of the pandemic, supporting R&D teams working on ground-breaking vaccines, anti-virals, and diagnostics.
We are now evaluating prospective studies that collect subjects:
- With active respiratory infection symptoms (COVID, influenza, RSV)
- Recovered from breakthrough COVID infections
- At multiple timepoints (biospecimens, clinical metadata, or both)
- Treated with specific therapies
Swabs, saliva, blood, serum, plasma, and other biospecimens are possible as is comprehensive clinical metadata including symptomology, co-morbidities, and vaccination history. All prospectively collected subjects are fully consented with all use rights provided.